Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 104851-104900 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT04097158
Biomarkers in Different Types of Amyotrophic Lateral Sclerosis (ALS) Patients Being Treated With Edaravone
N/A
Recruiting
160 participants
Started: Oct 8, 2019 · Completed: Apr 30, 2026
1 condition
5 sponsors
1 location
NCT04293796
Refusal of Breast Surgery in Patients With Breast Cancer With a Clinical Complete Response (cCR) After Neoadjuvant Systemic Therapy and a Confirmed Pathological Complete Response (pCR) Using Vacuum-assisted Biopsy (VAB) and Sentinel Lymph Node Biopsy (SLNB)
NA
Recruiting
60 participants
Started: Oct 8, 2019 · Completed: Dec 10, 2028
1 condition
1 sponsor
1 location
NCT04083430
Cytotoxicity of Yellow Fever Specific CD8 T Cells Following YF-17D Vaccination
PHASE4
Active, not recruiting
60 participants
Started: Oct 8, 2019 · Completed: Dec 15, 2025
3 conditions
1 sponsor
1 location
NCT03839758
Study of Personalized Instrument in Total Shoulder Arthroplasty The P.I.T.S.A. Study
NA
Recruiting
112 participants
Started: Oct 8, 2019 · Completed: Dec 31, 2028
1 condition
1 sponsor
1 location
NCT04132206
Longitudinal Characterization of Microbial Signature in Systemic Sclerosis Patients
N/A
Recruiting
60 participants
Started: Oct 8, 2019 · Completed: Jun 3, 2026
1 condition
1 sponsor
1 location
NCT04122742
Diagnosis of RSTS: Identification of the Acetylation Profiles as Epigenetic Markers for Assessing Causality of CREBBP and EP300 Variants.
N/A
Recruiting
154 participants
Started: Oct 8, 2019 · Completed: Oct 31, 2025
1 condition
1 sponsor
1 location
NCT04050436
Study Evaluating Cemiplimab Alone and Combined With RP1 in Treating Advanced Squamous Skin Cancer
PHASE2
Active, not recruiting
231 participants
Started: Oct 8, 2019 · Completed: Sep 30, 2025
3 conditions
2 sponsors
56 locations
NCT04602091
Observational Study in Patients Treated With JAK Inhibitors for Inflammatory Rheumatism (MAJIK)
N/A
Active, not recruiting
2,300 participants
Started: Oct 8, 2019 · Completed: Jun 30, 2030
4 conditions
2 sponsors
60 locations
NCT03905603
Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS
EARLY_PHASE1
Recruiting
144 participants
Started: Oct 8, 2019 · Completed: May 1, 2026
1 condition
1 sponsor
1 location
NCT03807401
A Technical Innovation of Prismatic Adaptation Test in Healthy Subject, in Favour of Autonomy and Independence in Daily Life Following a Brain Injury
NA
Recruiting
480 participants
Started: Oct 8, 2019 · Completed: Apr 8, 2026
1 condition
1 sponsor
1 location
NCT03909412
Carfilzomib Based Chemotherapy Mobilization for Autologous Stem Cell Transplants in Multiple Myeloma
PHASE1
Recruiting
18 participants
Started: Oct 8, 2019 · Completed: Oct 31, 2025
1 condition
1 sponsor
1 location
NCT03953300
Benralizumab Airway Remodeling Study in Severe Eosinophilic Asthmatics
PHASE4
Active, not recruiting
74 participants
Started: Oct 8, 2019 · Completed: Sep 9, 2026
1 condition
1 sponsor
35 locations
NCT04451473
Lung Surgery With Enhanced Recovery VS. Lung Surgery Without Enhanced Recovery
NA
Recruiting
350 participants
Started: Oct 8, 2019 · Completed: Jun 30, 2027
3 conditions
1 sponsor
1 location
NCT04291651
UCSF PANC Cyst Registry
N/A
Recruiting
4,000 participants
Started: Oct 8, 2019 · Completed: Jan 1, 2030
8 conditions
1 sponsor
1 location
NCT04199000
Clinical and Basic Investigations Into Congenital Disorders of Glycosylation
N/A
Recruiting
500 participants
Started: Oct 8, 2019 · Completed: Jul 31, 2030
1 condition
14 sponsors
12 locations
NCT04037254
Testing the Addition of a New Anti-Cancer Drug, Niraparib, to the Usual Treatment (Hormone and Radiation Therapy) for Prostate Cancer With a High Chance of Recurring
PHASE1/PHASE2
Active, not recruiting
22 participants
Started: Oct 8, 2019 · Completed: Sep 26, 2025
7 conditions
2 sponsors
95 locations
NCT03833440
Precision Immuno-Oncology for Advanced Non-small Cell Lung Cancer Patients With PD-1 ICI Resistance
PHASE2
Active, not recruiting
114 participants
Started: Oct 8, 2019 · Completed: Feb 28, 2025
1 condition
1 sponsor
1 location
NCT04121780
Growth Hormone Replacement Therapy for Retried Professional Football Players
PHASE2
Recruiting
42 participants
Started: Oct 8, 2019 · Completed: Sep 30, 2026
6 conditions
2 sponsors
1 location
NCT04404530
Nutritional Impacts of Palynziq on Patients With Phenylketonuria (PKU)
N/A
Recruiting
45 participants
Started: Oct 8, 2019 · Completed: Nov 30, 2027
1 condition
2 sponsors
2 locations
NCT04010955
Adding Antiplatelet During Edoxaban Treatment in Stroke Patients With Non-valvular Atrial Fibrillation (ADD-ON)
N/A
Active, not recruiting
1,200 participants
Started: Oct 8, 2019 · Completed: Jun 27, 2026
8 conditions
15 sponsors
1 location
NCT04131166
Precision Nutrition and Metabolic Function
NA
Active, not recruiting
300 participants
Started: Oct 8, 2019 · Completed: Dec 31, 2029
2 conditions
2 sponsors
1 location
NCT03474692
Virta Health Registry
N/A
Active, not recruiting
50,000 participants
Started: Oct 7, 2019 · Completed: Oct 31, 2039
5 conditions
1 sponsor
1 location
NCT03892655
Real World Study of Biosimilar Trastuzumab in Her2 Positive Breast Cancer
N/A
Active, not recruiting
170 participants
Started: Oct 7, 2019 · Completed: Jul 31, 2028
1 condition
1 sponsor
22 locations
NCT03910972
Sm-TSP-2 Schistosomiasis Vaccine in Healthy Ugandan Adults
PHASE1/PHASE2
Active, not recruiting
290 participants
Started: Oct 7, 2019 · Completed: Sep 30, 2025
2 conditions
3 sponsors
1 location
NCT05201131
Canadian Cohort of Convective Thermal Therapy Using Rezūm System in Benign Prostatic Hyperplasia (BPH).
N/A
Recruiting
50 participants
Started: Oct 7, 2019 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT04126200
Platform Study of Belantamab Mafodotin as Monotherapy and in Combination With Anti-cancer Treatments in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)
PHASE2
Active, not recruiting
209 participants
Started: Oct 7, 2019 · Completed: Feb 12, 2029
1 condition
1 sponsor
40 locations
NCT04123626
A Study to Evaluate the Safety and Tolerability of QR-1123 in Subjects With Autosomal Dominant Retinitis Pigmentosa Due to the P23H Mutation in the RHO Gene
PHASE1/PHASE2
Active, not recruiting
11 participants
Started: Oct 7, 2019 · Completed: Jun 7, 2022
8 conditions
1 sponsor
5 locations
NCT03983512
PULSTA Transcatheter Pulmonary Valve Pre-Approval Study
NA
Active, not recruiting
58 participants
Started: Oct 7, 2019 · Completed: Dec 31, 2026
4 conditions
2 sponsors
11 locations
NCT04293042
Treatment of BK Virus Infection With CTL Cells in Immunocompromised Transplant Patients
EARLY_PHASE1
Recruiting
20 participants
Started: Oct 7, 2019 · Completed: Dec 30, 2028
1 condition
1 sponsor
1 location
NCT04016246
Respiratory Effect of the LISA Method with Sedation by Propofol Versus Absence of Sedation.
PHASE3
Active, not recruiting
233 participants
Started: Oct 7, 2019 · Completed: Oct 31, 2026
1 condition
1 sponsor
13 locations
NCT03976063
Tocolysis in the Management of Preterm Premature Rupture of Membranes Before 34 Weeks of Gestation
PHASE3
Recruiting
850 participants
Started: Oct 7, 2019 · Completed: Nov 30, 2030
1 condition
4 sponsors
1 location
NCT04040205
Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration
PHASE2
Recruiting
44 participants
Started: Oct 7, 2019 · Completed: Jun 1, 2027
3 conditions
1 sponsor
4 locations
NCT03529422
Durvalumab With Radiotherapy for Adjuvant Treatment of Intermediate Risk SCCHN
PHASE2
Active, not recruiting
18 participants
Started: Oct 7, 2019 · Completed: May 6, 2026
4 conditions
2 sponsors
3 locations
NCT03962166
Characterizing Patients With POAF in Relation to Cardiac Surgery by wavECG and TTE
N/A
Active, not recruiting
353 participants
Started: Oct 7, 2019 · Completed: Dec 31, 2026
2 conditions
2 sponsors
1 location
NCT04141462
EXOME Analysis Position in the Strategy of Genetic Predisposition Factors Identification in Early-onset Cancer
NA
Recruiting
613 participants
Started: Oct 7, 2019 · Completed: Apr 7, 2028
2 conditions
1 sponsor
6 locations
NCT04100200
Berries, Inflammation, and Gut Microbiome
NA
Active, not recruiting
105 participants
Started: Oct 7, 2019 · Completed: Jan 1, 2026
2 conditions
2 sponsors
1 location
NCT04113993
Bazedoxifene -Treatment for Women With Schizophrenia
PHASE4
Recruiting
160 participants
Started: Oct 7, 2019 · Completed: Dec 31, 2025
3 conditions
3 sponsors
1 location
NCT04501419
Tablet-based Mobile Health Ultrasound for Point-of-care Breast Cancer Diagnosis in Nigeria
NA
Recruiting
600 participants
Started: Oct 5, 2019 · Completed: Jun 30, 2026
1 condition
2 sponsors
1 location
NCT03815890
Pre-operative Trial for Breast Cancer With Nivolumab in Combination With Novel IO
PHASE2
Recruiting
80 participants
Started: Oct 4, 2019 · Completed: Jan 1, 2033
1 condition
2 sponsors
1 location
NCT04082897
ObinutuzuMab AtezOlizumab and VenetocLax in RichTer transfOrmation
PHASE2
Active, not recruiting
28 participants
Started: Oct 4, 2019 · Completed: Dec 31, 2026
1 condition
1 sponsor
17 locations
NCT04344769
Characterization of the Nrf2 Response in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
N/A
Recruiting
40 participants
Started: Oct 4, 2019 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT03830788
Erectile Dysfunction in Good Prognosis Prostate Cancer : Comparison Between Brachytherapy and Stereotactic Body Radiotherapy
NA
Recruiting
240 participants
Started: Oct 4, 2019 · Completed: Apr 4, 2031
1 condition
1 sponsor
20 locations
NCT04007029
Modified Immune Cells (CD19/CD20 CAR-T Cells) in Treating Patients With Recurrent or Refractory B-Cell Lymphoma or Chronic Lymphocytic Leukemia
PHASE1
Active, not recruiting
24 participants
Started: Oct 4, 2019 · Completed: Aug 1, 2027
14 conditions
2 sponsors
1 location
NCT04034433
Exercise Program for Arteriovenous Fistula Maturation
NA
Recruiting
40 participants
Started: Oct 4, 2019 · Completed: Nov 4, 2026
1 condition
1 sponsor
1 location
NCT04236882
Sleep and Physical Activity Intervention for Increasing Physical Activity in Overweight or Obese and Sedentary African Americans
NA
Active, not recruiting
28 participants
Started: Oct 4, 2019 · Completed: Apr 30, 2030
2 conditions
2 sponsors
2 locations
NCT04067700
CPET in Myocardial Ischemia
NA
Recruiting
100 participants
Started: Oct 3, 2019 · Completed: Sep 30, 2028
1 condition
1 sponsor
1 location
NCT03805932
Moxetumomab Pasudotox-tdfk (Lumoxiti(TM)) and Either Rituximab (Rituxan(R)) or Ruxience for Relapsed Hairy Cell Leukemia
PHASE1
Active, not recruiting
18 participants
Started: Oct 3, 2019 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT04100148
SyncAV Post-Market Trial
NA
Active, not recruiting
1,686 participants
Started: Oct 3, 2019 · Completed: Dec 31, 2025
1 condition
1 sponsor
103 locations
NCT03866148
Obstructive Sleep Apnoea and Cardiac Arrhythmias
NA
Active, not recruiting
200 participants
Started: Oct 3, 2019 · Completed: Apr 15, 2025
4 conditions
1 sponsor
1 location
NCT04203303
Implications of the Human Microbiota for Health and Disease
N/A
Recruiting
5,000 participants
Started: Oct 3, 2019 · Completed: Dec 31, 2030
1 condition
1 sponsor
1 location
Previous
1
More pages
2095
2096
2097
2098
2099
2100
2101
More pages
2369
Next